Disease activity, organ involvement, and treatment choice all shape infection risk in lupus and rheumatoid arthritis, with ...
Our most recent episode of The Expert Series podcast “Your Lupus Treatment Roadmap: Understanding the New Guidelines and What They Mean for You” explores the newly released SLE treatment guidelines ...
Two investigational drugs for lupus with encouraging primary phase II results yielded more good news from follow-on studies, ...
For the first time in decades, targeted therapies to treat cutaneous lupus erythematosus are advancing through the research pipeline, driven by both dermatologic and rheumatologic advancements, ...
Margrit Wiesendanger, MD, PhD, discusses how lupus treatment is evolving from traditional therapies to more targeted options like biologics, with promising advances now being explored in clinical ...
Johnson & Johnson (NYSE: JNJ) today announced nipocalimab met the primary endpoint of decreasing disease activity at 24 weeks as measured by SLE Responder Index 4 (SRI-4)b and continued to demonstrate ...
A doctor advising … sleepaway camp? That’s how a 12-year-old diagnosed with lupus found himself laughing on a high-ropes course as fellow campers hoisted him into the air. “It’s really fun,” said ...
When dairy farmer Brie Hyde began experiencing chronic fatigue and joint pain, doctors treated her for Lyme disease. After years of worsening symptoms, she was diagnosed with Lupus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results